Fragmin
Company: Pharmacia & UpjohnApproval Status: Approved March 1999
Treatment for: Hematology
Areas: Hematology
General Information
Fragmin Injection is indicated for prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism:
- In patients undergoing hip replacement surgery
- In patients undergoing abdominal surgery who are at risk for thromboembolic complications.
Patients at risk include those who are over 40 years of age, obese, undergoing surgery under general anesthesia lasting longer than 30 minutes, or who have additional risk factors such as malignancy, or a history of deep venous thrombosis or pulmonary embolism.
Fragmin Drug Information
The Fragmin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
